Computer-Aided Detection and diagnosis for prostate cancer based on mono and multi-parametric MRI: A review

https://doi.org/10.1016/j.compbiomed.2015.02.009Get rights and content

Highlights

  • Techniques used in mono and multi-parametric MRI CADe and CADx for CaP are reviewed.

  • A comparison between the different studies is given.

  • The contribution of multi-parametric CAD compared with mono-parametric is discussed.

  • Potential avenues for future research are discussed.

  • A public multi-parametric MRI database is brought to the community׳s knowledge.

Abstract

Prostate cancer is the second most diagnosed cancer of men all over the world. In the last few decades, new imaging techniques based on Magnetic Resonance Imaging (MRI) have been developed to improve diagnosis. In practise, diagnosis can be affected by multiple factors such as observer variability and visibility and complexity of the lesions. In this regard, computer-aided detection and computer-aided diagnosis systems have been designed to help radiologists in their clinical practice. Research on computer-aided systems specifically focused for prostate cancer is a young technology and has been part of a dynamic field of research for the last 10 years. This survey aims to provide a comprehensive review of the state-of-the-art in this lapse of time, focusing on the different stages composing the work-flow of a computer-aided system. We also provide a comparison between studies and a discussion about the potential avenues for future research. In addition, this paper presents a new public online dataset which is made available to the research community with the aim of providing a common evaluation framework to overcome some of the current limitations identified in this survey.

Introduction

During the last century, physicists have focused on constantly innovating in terms of imaging techniques assisting radiologists to improve cancer detection and diagnosis. However, human diagnosis still suffers from low repeatability, synonymous with erroneous detection or interpretations of abnormalities throughout clinical decisions [1], [2]. These errors are driven by two majors causes [1]: observer limitations (e.g., constrained human visual perception, fatigue or distraction) and the complexity of the clinical cases themselves, for instance due to unbalanced data (number of healthy cases more abundant than malignant cases) or overlapping structures.

Computer vision has given rise to many promising solutions, but, instead of focusing on fully automatic computerized systems, researchers have aimed at providing computer image analysis techniques to aid radiologists in their clinical decisions [1]. In fact, these investigations brought about both concepts of Computer-Aided Detection (CADe) and Computer-Aided Diagnosis (CADx) grouped under the acronym CAD. Since those first steps, evidence has shown that CAD systems enhance the diagnosis performance of radiologists. Chan et al. reported a significant 4% improvement in breast cancer detection [3], which has been confirmed in later studies [4]. Similar conclusions were drawn in the case of lung nodule detection [5], colon cancer [6] and Prostate Cancer CaP as well [2]. Chan et al. also hypothesized that CAD systems will be even more efficient assisting inexperienced radiologists than senior radiologists [3]. This hypothesis was tested by Hambrock et al. [2] and was confirmed in the case of CaP detection. In this particular study, inexperienced radiologists obtained equivalent performance to senior radiologists, both using CAD whereas the accuracy of their diagnosis was significantly poorer without CAD׳s help.

In contradiction with the aforementioned statement, CAD for CaP is a young technology due to the fact that it is based on Magnetic Resonance Imaging (MRI) [7]. Four distinct MRI modalities are employed in CaP diagnosis which were mainly developed after the mid-1990s: (i) T2 Weighted (T2-W) MRI [8], (ii) Dynamic Contrast-Enhanced (DCE) MRI [9], (iii) Magnetic Resonance Spectroscopy Imaging (MRSI) [10] and (iv) Diffusion Weighted (DW) MRI [11]. In addition, the increase of magnetic field strength (from 1.5 to 3 Tesla) and the development of endorectal coils, both improved image spatial resolution [12] needed to perform more accurate diagnosis. It is for this matter that the development of CAD for CaP is still lagging behind the other fields stated above.

The first study on CAD for MRI was published in 2003 by Chan et al. [13]. Despite this, no less than 50 studies have been reviewed for this survey since that seminal work. To the best of our knowledge, there is no fully detailed review in the literature regarding the advancement of CAD systems devoted specifically to CaP detection and diagnosis. Only the recent work of [14] briefly covers a reduced number of current research works on CAD for CaP (a total of 70 references), but it does not provide a detailed description of any of the steps of a CAD system as it is done here with more than 200 references. Moreover, a new categorization is proposed in this work taking the clinical and technical aspects of a CAD system into account. Thus, the aim of this survey is threefold: (i) provide an overview and categorization of the developed CAD systems for CaP detection and diagnosis based on MRI modalities (ii) assess the different works and (iii) point out avenues for future directions.

We also would like to emphasize the fact that this study will review the details of the computer vision aspects of the different studies. Thus, this survey is more intended for a medical imaging audience rather than a purely experimented clinical audience.

As discussed further in Section 2.2.3, we identified and characterized a common framework regarding the CAD systems. Stages involved in CAD work-flow can be categorized into three distinctive processes: (i) image regularization, (ii) CADe, (iii) CADx (see Fig. 1). Image regularization focuses on formatting the data while CADe and CADx allow us to detect possible lesions and distinguish malignant from non-malignant tumours, respectively.

This paper is organized as follows: Section 2 deals with general information about human prostate and background about CaP. Methods regarding CaP screening and imaging techniques used are also presented as well as an introduction to the CAD framework. 3 Image regularization framework, 4 CADe–CADx review techniques used in different steps involved in a CAD work-flow which will be our main contribution. Image regularization framework including pre-processing (Section 3.1), segmentation (Section 3.2) and registration (Section 3.3) will be covered as well as CADe and CADx strategies (Section 4) identified. Results and discussion are reported in Section 5 followed by a concluding section. Deriving from this discussion, we make available to the research community a public online dataset aiming at overcoming some of the drawbacks found when evaluating research in this field.

Section snippets

Background

This section provides an overview of CaP as well as its detection and diagnosis. MRI plays an important role in improving the current strategy and a more detailed description of MRI modalities is given. Furthermore, a discussion regarding the aim of CAD systems is also given.

Image regularization framework

This section provides a review of the methods used in CADs for CaP in order to regularize input images. We start with pre-processing methods presented in Section 3.1, focusing mainly on the reduction of noise level and artifacts as well as standardization of SI. 3.2 Segmentation, 3.3 Registration will be dedicated to segmentation methods, so that later methods only operate on the segmented prostate, and registration to align segmented images from different MRI-modalities in the same reference

CADe: ROIs detection/selection

As discussed in the introduction and shown in Fig. 1, the image classification framework is often composed of a CADe and a CADx. In this section, we will focus on studies embedding a CADe in their framework. Two approaches are considered to define a CADe (see Table 6): (i) voxel-based delineation and (ii) lesion segmentation. The first strategy, which concerns the majority of the studies reviewed (see Table 6), is in fact linked to the nature of the classification framework [114], [115], [163],

Results reported

As discussed previously in Section 4.4.3, different metrics have been used to report results. A comparison of the different methods reviewed is given depending on the metric used in field of research and also the type of MRI scanner used (cf., 1.5 versus 3.0 Tesla). For each field, the best performances obtained in each study were reported in these figures. The results given in terms of AUC-ROC are depicted in Fig. 9. The results vary between 71% and 97% for some experiments with a 1.5 Tesla MRI

Conclusion

This review has presented an overview and classification of the research related to CAD development for CaP using multi-parametric MRI data. We aimed at providing background information regarding multi-parametric MRI imaging techniques and a description of the work-flow in the different CAD stages. The methods used in the literature for each of these stages have been reviewed along with the available results of the CAD systems. Moreover, insight discussions and possible future research

Conflict of interest statement

The authors declare no conflict of interest.

Acknowledgments

G. Lemaître was supported by the Generalitat de Catalunya (Grant no. FI-DGR2012) and partly by the Mediterranean Office for Youth (Grant no. 2011/018/06).

We would like to acknowledge Sharad Nagappa for all the discussions involved and his precious advices and corrections regarding the reduction of this entire manuscript.

References (218)

  • T. Hambrock et al.

    Prostate cancercomputer-aided diagnosis with multiparametric 3-T MR imaging–effect on observer performance

    Radiology

    (2013)
  • H.P. Chan et al.

    Improvement of radiologists׳ characterization of mammographic masses by using computer-aided diagnosisan ROC study

    Radiology

    (1999)
  • J.C. Dean et al.

    Improved cancer detection using computer-aided detection with diagnostic and screening mammographyprospective study of 104 cancers

    AJR Am. J. Roentgenol.

    (2006)
  • F. Li et al.

    Radiologists׳ performance for differentiating benign from malignant lung nodules on high-resolution CT using computer-estimated likelihood of malignancy

    AJR Am. J. Roentgenol.

    (2004)
  • N. Petrick et al.

    CT colonography with computer-aided detection as a second readerobserver performance study

    Radiology

    (2008)
  • J.V. Hegde et al.

    Multiparametric MRI of prostate canceran update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer

    J. Magn. Reson. Imaging

    (2013)
  • H. Hricak et al.

    Anatomy and pathology of the male pelvis by magnetic resonance imaging

    AJR Am. J. Roentgenol.

    (1983)
  • R.A. Huch Boni et al.

    Contrast-enhanced endorectal coil MRI in local staging of prostate carcinoma

    J. Comput. Assist. Tomogr.

    (1995)
  • J. Kurhanewicz et al.

    Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm3) spatial resolution

    Radiology

    (1996)
  • J. Scheidler, R. Petsch, U. Muller-Lisse, A. Heuck, M. Reiser, Echo-planar diffusion-weighted MR imaging of the...
  • M.G. Swanson et al.

    Single-voxel oversampled J-resolved spectroscopy of in vivo human prostate tissue

    Magn. Reson. Med.

    (2001)
  • I. Chan et al.

    Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier

    Med. Phys.

    (2003)
  • S. Wang et al.

    Computer Aided-Diagnosis of prostate cancer on multiparametric MRIa technical review of current research

    BioMed. Res. Int.

    (2014)
  • J. Ferlay et al.

    Estimates of worldwide burden of cancer in 2008GLOBOCAN 2008

    Int. J. Cancer

    (2010)
  • R. Siegel et al.

    Cancer statistics

    CA Cancer J. Clin.

    (2013)
  • A.C. American Cancer Society, Cancer Facts and Figures 2013, 〈http://www.cancer.org/research/cancerfactsfigures〉, 2013...
  • A.C. American Cancer Society, Cancer Facts and Figures 2010, 〈http://www.cancer.org/research/cancerfactsfigures〉, 2010...
  • E. Giovannucci et al.

    Risk factors for prostate cancer incidence and progression in the health professionals follow-up study

    Int. J. Cancer

    (2007)
  • G.D. Steinberg et al.

    Family history and the risk of prostate cancer

    Prostate

    (1990)
  • M.L. Freedman et al.

    Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men

    Proc. Natl. Acad. Sci. U.S.A.

    (2006)
  • L.T. Amundadottir et al.

    A common variant associated with prostate cancer in European and African populations

    Nat. Genet.

    (2006)
  • I. Agalliu et al.

    Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations

    Clin. Cancer Res.

    (2009)
  • R.M. Hoffman et al.

    Racial and ethnic differences in advanced-stage prostate cancerthe Prostate Cancer Outcomes Study

    J. Natl. Cancer Inst.

    (2001)
  • R.W. Ma et al.

    A systematic review of the effect of diet in prostate cancer prevention and treatment

    J. Hum. Nutr. Diet.

    (2009)
  • D.D. Alexander et al.

    A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer

    Nutr. J.

    (2010)
  • C. Rodriguez et al.

    Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

    Cancer Epidemiol. Biomark. Prev.

    (2007)
  • S. Strum et al.

    What every doctor who treats male patients should know

    PCRI Insights

    (2005)
  • G.L. Lu-Yao et al.

    Outcomes of localized prostate cancer following conservative management

    J. Am. Med. Assoc.

    (2009)
  • G. Oster et al.

    Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bonea 15-year study in two large US health systems

    Support Care Cancer

    (2013)
  • L. Ye et al.

    Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review)

    Int. J. Mol. Med.

    (2007)
  • C.L. Carrol et al.

    The abnormal prostateMR imaging at 1.5 T with histopathologic correlation

    Radiology

    (1987)
  • J.E. McNeal et al.

    Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

    Am. J. Surg. Pathol.

    (1988)
  • R. Chou et al.

    Screening for prostate cancera review of the evidence for the U.S. Preventive Services Task Force

    Ann. Intern. Med.

    (2011)
  • G.L. Andriole et al.

    Mortality results from a randomized Prostate-cancer screening trial

    New Engl. J. Med.

    (2009)
  • F.H. Schröder et al.

    Prostate-cancer mortality at 11 years of follow-up

    New Engl. J. Med.

    (2012)
  • A. Bourdoumis et al.

    The novel prostate cancer antigen 3 (PCA3) biomarker

    Int. Braz. J. Urol.

    (2010)
  • R. Morgan et al.

    Engrailed-2 (EN2)a tumor specific urinary biomarker for the early diagnosis of prostate cancer

    Clin. Cancer Res.

    (2011)
  • J. Brenner et al.

    ETS fusion genes in prostate cancer

  • C.M. Hoeks et al.

    Prostate cancermultiparametric MR imaging for detection, localization, and staging

    Radiology

    (2011)
  • C.M. Moore et al.

    The role of MRI in active surveillance of prostate cancer

    Curr. Opin. Urol.

    (2013)
  • Cited by (0)

    View full text